Ефикасност на конзервативниот третман со ботулинум токсин кај хипертофија на масетеричен мускул

Mijoska, Aneta and Petkov, Marjan and Denkovski, Marijan and Bajraktarova Valjakova, Emilija and Trpevska, Vesna and Stojanovski, Ivan and Stojanovska, Magdalena and Naumovski, Borjan (2024) Ефикасност на конзервативниот третман со ботулинум токсин кај хипертофија на масетеричен мускул. Vox Dentarii (56). pp. 30-34. ISSN 1857-7814

Text Ефикасност на конзервативниот третман со ботулинум токсин кај хипертрофија на масетеричниот мускул.pdf - Published Version Download (1MB)

Abstract

Introduction: Bruxism is defined as recurrent masticatory muscle activity. The masseter muscle contributes approximately 43% of the total strength of the jaw closure muscles. Muscle hypertrophy as a result of long-term bruxism often occurs and is most commonly seen in masseter muscle among the masticatory muscles. Although there is not an agreed treatment method for bruxism, the application of botulinum toxin has become reliable lately.
Methodology: Botulinum toxin type A, (DYSPORT 500, Ipsen Biopharm, UK) was used for the therapy of muscle disorder bruxism or night teeth clenching in a female patient 26 years old. The Fonseca Anamnestic Index was applied to determine clenching habits and depression levels before the treatment, and 3 months after. Depending on the dose applied to the targeted muscle, a complete or partial reduction in contraction occurs with reduced function and weakening of the muscle. A application patient had severe TMD (score 50), and two weeks after applying the neuromodulator, the patient reported a reduction in pain and episodes of teeth grinding and clenching. Bilateral hypotrophy of left and right masseter muscles was noticeable after 3 months.
Purpose: The purpose of this paper is to describe the conservative treatment of bruxism, accompanied by masseteric muscle hypertrophy.
Conclusions: We concluded that botulinum toxin could be used as an effective treatment for reducing nocturnal bruxism and myofascial pain in patients with bruxism.
Results: According to the Fonseca Anamnestic Index, which was conducted before the BT
Keywords: botulinum toxin, neuromodulator, TMJ, bruxism

Item Type:	Article
Subjects:	Medical and Health Sciences > Basic medicine Medical and Health Sciences > Clinical medicine Medical and Health Sciences > Health biotechnology Medical and Health Sciences > Health sciences Medical and Health Sciences > Other medical sciences
Divisions:	Faculty of Medical Science
Depositing User:	Vesna Trpevska
Date Deposited:	07 Oct 2024 10:38
Last Modified:	07 Oct 2024 10:38
URI:	https://eprints.ugd.edu.mk/id/eprint/34780

Actions (login required)

View Item